Myanmar-focused MySQUAR (LON:MYSQ) has raised £324,000 through a warrant issue at 3.5p. Shares in the internet-based mobile group have more than trebled over the past month.
Eurasia Mining plc (LON:EUA) is looking to refinance with a director’s loan as it steps up production at the West Kytlim alluvial platinum mine in Russia. A loan arrangement with third parties and Dmitry Suschov, a director of the company, for £1.6mln will repay the existing Sanderson loan arrangement, though the details have yet to be confirmed.
Shares in Greatland Gold PLC (LON:GGP) shot up 19% after it signed a deal with giant Newmont Mining Corp (NYSE:NEM), which it said could “accelerate the realisation of the potential value” of the Ernest Giles Project in Western Australia.
The New York-listed major has been granted exclusive access to the tenements and exploration database for six months and has the right of first refusal should the Greatland opt to sell or joint venture the asset in that period.
Portfolio analytics software developer StatPro Group PLC (LON:SOG) has handed over the first wodge of cash relating to its purchase of UBS Delta. An initial payment of €8.7mln has been made; in total, the company will pay around €13mln over three years.
An improvement in US sales of its PIFA Heparin PF/4 rapid assay products leaves Akers Biosciences Inc (NASDAQ:AKER, LON:AKR) poised for growth in 2017. Domestic US sales of PIFA Heparin PF/4 rapid assay products were up 2.3% quarter-on-quarter at US$560,921.
Life sciences group OptiBiotix Health plc (LON:OPTI) has told investors that its health supplements were a massive hit when they were launched at the Vitafoods Europe tradeshow in Geneva last week. Opti said it has already received draft contracts from several companies at the fair which are interested in selling its CholBiome, CardioBiome and SlimBiome products.
India and Finland focussed junior miner Lionsgold Limited (LON:LION) has told investors that IndexGold, the company’s financial technology app, has now been released. IndexGold is an online platform that allows investors to take direct ownership of physical gold and silver. Parry highlighted that the launch of the app gives the group a revenue generating fintech gold division.
Pioneering cancer treatment group Nanobiotix PLC (EPA:NANO) booked no revenues in its latest quarter as its milestone payments with Asia partner Pharma Engine were recognised last year. The Paris-based group has a raft of trial results and updates due over the remainder of the year.
Oilfield drilling equipment renter Plexus Holdings PLC (LON:POS) is still being affected by new wells being postponed due to the weak oil price. Trading remains challenging with discussions over contracts taking longer than expected to conclude it said, though Plexus still anticipates order under negotiation will come through next year, to June 2018.
Union Jack Oil PLC (LON:UJO) executive chairman David Bramhill, in its financial results statement, described 2016 as “one of solid progress”. The onshore UK oil company noted operational highlights such as the competent persons report which estimated 14.8mln barrels of oil equivalent at UJO’s (now) 15% owned Wressle field.
Silence Therapeutics PLC (LON:SLN) has filed for more patent protection for its RNA therapeutics/gene silencing technology and intends to seek payment for a number of drugs already in late-stage development.
“We believe this patented technology is relevant to third party medicines in ongoing clinical trials for conditions including, but not exclusively limited to, Hypercholesterolemia, TTR-mediated Amyloidosis, Haemophilia and Acute Hepatic Porphyrias.”
Chaarat Gold Holdings Ltd (LON:CGH) is to co-host an Investment Forum on 25th May with the Embassy of the Kyrgyz Republic and the European Bank for Reconstruction and Development (EBRD) to improve the international investor perception of the country's operating environment.
An improvement in US sales of its PIFA Heparin PF/4 rapid assay products leaves Akers Biosciences Inc (NASDAQ:AKER, LON:AKR) poised for growth in 2017. Last month the rapid diagnostics specialist reported strong sales of the PIFA PF/4 device in the second half of 2016 and this morning it revealed the sales momentum had continued in the first three months of 2017.
Tharisa PLC (LON:THS) more than doubled revenues to US$175 mln in the half year to March 31st 2017, while earnings before interest, tax, depreciation and amortization rose by more than 451% to US$81 mln.
The strong performance came as the company mined nearly 4% more ore from its chrome and platinum mines in South Africa, and boosted recoveries significantly such that platinum group metals concentrate produce rose by 15.2% and chrome concentrate by 5.4%.